References
- Azuma, Y., Kaji, K., Katogi, R., Takeshita, S. and Kudo, A. (2000) Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J. Biol. Chem. 275, 4858-4864. https://doi.org/10.1074/jbc.275.7.4858
- Baumann, B., Bohnenstengel, F., Siegmund, D., Wajant, H., Weber, C., Herr, I., Debatin, K.M., Proksch, P., and Wirth, T. (2002). Rocaglamide derivatives are potent inhibitors of NF-kappa B activation in T-cells. J. Biol. Chem. 277, 44791-44800. https://doi.org/10.1074/jbc.M208003200
- Bohnenstengel, F.I., Steube, K.G., Meyer, C., Nugroho, B.W., Hung, P.D., Kiet, L.C., and Proksch, P. (1999). Structure activity relationships of antiproliferative rocaglamide derivatives from Aglaia species (Meliaceae). Z. Naturforsch. C 54, 55-60.
- Canalis, E. (1987) Effects of tumor necrosis factor on bone formation in vitro. Endocrinology 121, 1596-1604. https://doi.org/10.1210/endo-121-5-1596
- Chang, J., Wang, Z., Tang, E., Fan, Z., McCauley, L., Franceschi, R., Guan, K., Krebsbach, P.H., and Wang, C.Y. (2009). Inhibition of osteoblastic bone formation by nuclear factor-kappaB. Nat. Med. 15, 682-689. https://doi.org/10.1038/nm.1954
- Chang, J., Liu, F., Lee, M., Wu, B., Ting, K., Zara, J.N., Soo, C., Al Hezaimi, K., Zou, W., Chen, X., et al. (2013). NF-kappaB inhibits osteogenic differentiation of mesenchymal stem cells by promoting beta-catenin degradation. Proc. Natl. Acad. Sci. USA 110, 9469-9474. https://doi.org/10.1073/pnas.1300532110
- Collett, G.P. and Campbell, F.C. (2006) Overexpression of p65/RelA potentiates curcumin-induced apoptosis in HCT116 human colon cancer cells. Carcinogenesis 27, 1285-1291. https://doi.org/10.1093/carcin/bgi368
- Dreyer, M., Nugroho, B.W., Bohnenstengel, F.I., Ebel, R., Wray, V., Witte, L., Bringmann, G., Muhlbacher, J., Herold, M., Hung, P.D., et al. (2001). New insecticidal rocaglamide derivatives and related compounds from Aglaia oligophylla. J. Nat. Prod. 64, 415-420. https://doi.org/10.1021/np000123x
- Goldring, S.R. and Gravallese, E.M. (2000) Pathogenesis of bone erosions in rheumatoid arthritis. Curr. Opin. Rheumatol 12, 195-199. https://doi.org/10.1097/00002281-200005000-00006
- Huang, W., Yang, S., Shao, J. and Li, Y.P. (2007) Signaling and transcriptional regulation in osteoblast commitment and differentiation. Front. Biosci. 12, 3068-3092. https://doi.org/10.2741/2296
- Kaneko, H., Arakawa, T., Mano, H., Kaneda, T., Ogasawara, A., Nakagawa, M., Toyama, Y., Yabe, Y., Kumegawa, M. and Hakeda, Y. (2000). Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. Bone 27, 479-486. https://doi.org/10.1016/S8756-3282(00)00358-6
- Karsenty, G., Kronenberg, H.M. and Settembre, C. (2009) Genetic control of bone formation. Annu. Rev. Cell Dev. Biol. 25, 629-648. https://doi.org/10.1146/annurev.cellbio.042308.113308
- Kim, S., Salim, A.A., Swanson, S.M., and Kinghorn, A.D. (2006). Potential of cyclopenta[b]benzofurans from Aglaia species in cancer chemotherapy. Anticancer Agents Med. Chem. 6, 319-345. https://doi.org/10.2174/187152006777698123
- Lee, S.K., Cui, B., Mehta, R.R., Kinghorn, A.D., and Pezzuto, J.M. (1998). Cytostatic mechanism and antitumor potential of novel 1H-cyclopenta[b]benzofuran lignans isolated from Aglaia elliptica. Chem. Biol. Interact. 115, 215-228. https://doi.org/10.1016/S0009-2797(98)00073-8
- Lee, H.L., Yi, T., Woo, K.M., Ryoo, H.M., Kim, G.S., and Baek, J.H. (2010). Msx2 mediates the inhibitory action of TNF-alpha on osteoblast differentiation. Exp. Mol. Med. 42, 437-445. https://doi.org/10.3858/emm.2010.42.6.045
- Li, Y.C., Ross, J., Scheppler, J.A., and Franza, B.R., Jr. (1991). An in vitro transcription analysis of early responses of the human immunodeficiency virus type 1 long terminal repeat to different transcriptional activators. Mol. Cell Biol. 11, 1883-1893. https://doi.org/10.1128/MCB.11.4.1883
- Li, Y., Li, A., Strait, K., Zhang, H., Nanes, M.S., and Weitzmann, M.N. (2007). Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB. J. Bone Miner Res. 22, 646-655. https://doi.org/10.1359/jbmr.070121
- McInnes, I.B., and Schett, G. (2007). Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 7, 429-442. https://doi.org/10.1038/nri2094
- Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63. https://doi.org/10.1016/0022-1759(83)90303-4
- Mukai, T., Otsuka, F., Otani, H., Yamashita, M., Takasugi, K., Inagaki, K., Yamamura, M. and Makino, H. (2007). TNF-alpha inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling. Biochem. Biophys. Res. Commun. 356, 1004-1010. https://doi.org/10.1016/j.bbrc.2007.03.099
- Nanjundaiah, S.M., Astry, B. and Moudgil, K.D. (2013) Mediators of inflammation-induced bone damage in arthritis and their control by herbal products. Evid. Based Complement Alternat. Med. 2013, 518094.
- Proksch, P., Giaisi, M., Treiber, M.K., Palfi, K., Merling, A., Spring, H., Krammer, P.H. and Li-Weber, M. (2005). Rocaglamide derivatives are immunosuppressive phytochemicals that target NF-AT activity in T cells. J. Immunol. 174, 7075-7084. https://doi.org/10.4049/jimmunol.174.11.7075
- Redlich, K., Hayer, S., Ricci, R., David, J.P., Tohidast-Akrad, M., Kollias, G., Steiner, G., Smolen, J.S., Wagner, E.F. and Schett, G. (2002). Osteoclasts are essential for TNF-alpha-mediated joint destruction. J. Clin. Invest. 110, 1419-1427. https://doi.org/10.1172/JCI0215582
- Smucker, J.D., Rhee, J.M., Singh, K., Yoon, S.T., and Heller, J.G. (2006). Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine 31, 2813-2819. https://doi.org/10.1097/01.brs.0000245863.52371.c2
- Stanford, C.M., Jacobson, P.A., Eanes, E.D., Lembke, L.A. and Midura, R.J. (1995) Rapidly forming apatitic mineral in an osteoblastic cell line (UMR 106-01 BSP). J. Biol. Chem. 270, 9420-9428. https://doi.org/10.1074/jbc.270.16.9420
- Steer, J.H., Kroeger, K.M., Abraham, L.J. and Joyce, D.A. (2000). Glucocorticoids suppress tumor necrosis factor-alpha expression by human monocytic THP-1 cells by suppressing transactivation through adjacent NF-kappa B and c-Jun-activating transcription factor-2 binding sites in the promoter. J. Biol. Chem. 275, 18432-18440. https://doi.org/10.1074/jbc.M906304199
- Walsh, N.C., Reinwald, S., Manning, C.A., Condon, K.W., Iwata, K., Burr, D.B. and Gravallese, E.M. (2009). Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis. J. Bone Miner Res. 24, 1572-1585. https://doi.org/10.1359/jbmr.090320
- Wong, D.A., Kumar, A., Jatana, S., Ghiselli, G., and Wong, K. (2008). Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). Spine J. 8, 1011-1018. https://doi.org/10.1016/j.spinee.2007.06.014
- Yamazaki, M., Fukushima, H., Shin, M., Katagiri, T., Doi, T., Takahashi, T. and Jimi, E. (2009) Tumor necrosis factor alpha represses bone morphogenetic protein (BMP) signaling by interfering with the DNA binding of Smads through the activation of NF-kappaB. J. Biol. Chem. 284, 35987-35995. https://doi.org/10.1074/jbc.M109.070540
- Zaidi, M. (2007) Skeletal remodeling in health and disease. Nat. Med. 13, 791-801. https://doi.org/10.1038/nm1593
- Zhu, J.Y., Giaisi, M., Kohler, R., Muller, W.W., Muhleisen, A., Proksch, P., Krammer, P.H. and Li-Weber, M. (2009). Rocaglamide sensitizes leukemic T cells to activation-induced cell death by differential regulation of CD95L and c-FLIP expression. Cell Death Differ. 16, 1289-1299. https://doi.org/10.1038/cdd.2009.42
- Zara, J.N., Siu, R.K., Zhang, X., Shen, J., Ngo, R., Lee, M., Li, W., Chiang, M., Chung, J., Kwak, J., et al. (2011). High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo. Tissue Eng. Part A 17, 1389-1399. https://doi.org/10.1089/ten.tea.2010.0555
Cited by
- Pilose antler peptide potentiates osteoblast differentiation and inhibits osteoclastogenesis via manipulating the NF-κB pathway vol.491, pp.2, 2017, https://doi.org/10.1016/j.bbrc.2017.07.091
- Effects of tanshinol on markers of bone turnover in ovariectomized rats and osteoblast cultures vol.12, pp.7, 2017, https://doi.org/10.1371/journal.pone.0181175
- Occlusal trauma inhibits osteoblast differentiation and bone formation through IKK‐NF‐κB signaling vol.91, pp.5, 2015, https://doi.org/10.1002/jper.18-0710
- Prohibitin ligands: a growing armamentarium to tackle cancers, osteoporosis, inflammatory, cardiac and neurological diseases vol.77, pp.18, 2015, https://doi.org/10.1007/s00018-020-03475-1
- The interactions between mTOR and NF‐κB: A novel mechanism mediating mechanical stretch‐stimulated osteoblast differentiation vol.236, pp.6, 2015, https://doi.org/10.1002/jcp.30184